Get started
Author

Giulia Barletta

Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients
2018 · Matteo Sarocchi, Francesco Grossi, et al. · The Oncologist · 87
Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System
2014 · Anna Truini, Angela Alama, et al. · Frontiers in Oncology · 78
PDF
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium
2023 · Talal El Zarif, Amin H. Nassar, et al. · Journal of Clinical Oncology · 74
PDF
Circulating Tumor DNA Reflects Tumor Metabolism Rather Than Tumor Burden in Chemotherapy-Naive Patients with Advanced Non–Small Cell Lung Cancer: 18 F-FDG PET/CT Study
2017 · Silvia Morbelli, Angela Alama, et al. · Journal of Nuclear Medicine · 52
PDF
Next Generation Sequencing in Non-Small Cell Lung Cancer: New Avenues Toward the Personalized Medicine
2014 · Simona Coco, Anna Truini, et al. · Current Drug Targets · 49
Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy
2017 · Simona Coco, Angela Alama, et al. · International Journal of Molecular Sciences · 47
PDF
Glyceraldehyde-3-phosphate dehydrogenase gene over expression correlates with poor prognosis in non small cell lung cancer patients
2013 · Roberto Puzone, Graziana Savarino, et al. · Molecular Cancer · 42
PDF
Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform
2015 · Irene Vanni, Simona Coco, et al. · International Journal of Molecular Sciences · 39
PDF
Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition
2014 · Simona Coco, Anna Truini, et al. · Targeted Oncology · 39
Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer
2017 · Carlo Genova, Giovanni Rossi, et al. · Expert Opinion on Drug Safety · 36
Expression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I–III Non-Small Cell Lung Cancer
2015 · Francesco Grossi, Maria Giovanna Dal Bello, et al. · Disease Markers · 36
PDF
Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
2023 · Carlo Genova, Roberta Tasso, et al. · Cells · 34
PDF
Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab
2019 · Carlo Genova, Simona Boccardo, et al. · Journal of Clinical Medicine · 32
PDF
Pemetrexed for the treatment of non-small cell lung cancer
2013 · Carlo Genova, Erika Rijavec, et al. · Expert Opinion on Pharmacotherapy · 30
Oral vinorelbine in the treatment of non-small-cell lung cancer
2014 · Giulia Barletta, Carlo Genova, et al. · Expert Opinion on Pharmacotherapy · 28
Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma
2017 · Anna Truini, Simona Coco, et al. · Oncotarget · 27
PDF
Free drugs in clinical trials and their potential cost saving impact on the National Health Service: A retrospective cost analysis in Italy
2013 · Francesco Grossi, Carlo Genova, et al. · Lung Cancer · 27
Immunotherapy-chemotherapy combinations for non-small cell lung cancer: current trends and future perspectives
2022 · Eugenia Cella, Lodovica Zullo, et al. · Expert Opinion on Biological Therapy · 26
CIMAvax-EGF, a therapeutic non-small cell lung cancer vaccine
2018 · Marco Tagliamento, Erika Rijavec, et al. · Expert Opinion on Biological Therapy · 25
Afatinib for the treatment of advanced non-small-cell lung cancer
2014 · Carlo Genova, Erika Rijavec, et al. · Expert Opinion on Pharmacotherapy · 23
Role of Immunotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer
2013 · Erika Rijavec, Carlo Genova, et al. · Future Oncology · 23
Ipilimumab (MDX-010) in the treatment of non-small cell lung cancer
2012 · Carlo Genova, Erika Rijavec, et al. · Expert Opinion on Biological Therapy · 19
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy
2022 · Melania Grottoli, Paolo Carrega, et al. · Cancers · 18
PDF
Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma
2015 · Simona Coco, Anna Truini, et al. · Journal of Thoracic Oncology · 18
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab
2024 · Carlo Genova, Silvia Marconi, et al. · Clinical and Experimental Medicine · 17
Works count: 77
Citation count: 1,122
H-index: 21
I10-index: 35
Year
Topic
Type